Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines
- 3 April 2003
- Vol. 21 (23) , 3219-3227
- https://doi.org/10.1016/s0264-410x(03)00237-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Controlled Trial of a Human Papillomavirus Type 16 VaccineNew England Journal of Medicine, 2002
- Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle VaccineJournal of Virology, 2002
- Effect of Preexisting Neutralizing Antibodies on the Anti-tumor Immune Response Induced by Chimeric Human Papillomavirus Virus-like Particle VaccinesVirology, 2001
- Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle VaccineJNCI Journal of the National Cancer Institute, 2001
- Viral Vectors for Gene TransferDrugs, 2000
- Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor modelProceedings of the National Academy of Sciences, 1998
- Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic ImmunizationVirology, 1996
- Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.Proceedings of the National Academy of Sciences, 1995
- Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM,and mucosal IgA antibodiesVirology, 1995
- Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.Proceedings of the National Academy of Sciences, 1992